BioSmart Co.Ltd

KQ:038460 Korea Electronic Equipment & Parts
Market Cap
$63.31 Million
₩92.70 Billion KRW
Market Cap Rank
#21642 Global
#1040 in Korea
Share Price
₩4640.00
Change (1 day)
-0.75%
52-Week Range
₩2630.00 - ₩6250.00
All Time High
₩14975.32
Categories
Companies in Korea Electronic Equipment & Parts
About

BioSmart Co.,Ltd. manufactures and sells magnetic stripe (MS) cards in South Korea. The company's magnetic stripe cards include credit cards, smart cards, traffic cards, securities cards, etc. It also sells card equipment, such as traffic card issuing machinery, smart card issuing machinery, credit card issuing machinery, etc.; provides card issuing services comprising MS card and IC chip persona… Read more

BioSmart Co.Ltd (038460) - Net Assets

Latest net assets as of September 2025: ₩178.85 Billion KRW

Based on the latest financial reports, BioSmart Co.Ltd (038460) has net assets worth ₩178.85 Billion KRW as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩287.99 Billion) and total liabilities (₩109.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩178.85 Billion
% of Total Assets 62.1%
Annual Growth Rate 13.98%
5-Year Change 33.79%
10-Year Change 120.14%
Growth Volatility 18.72

BioSmart Co.Ltd - Net Assets Trend (2010–2024)

This chart illustrates how BioSmart Co.Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for BioSmart Co.Ltd (2010–2024)

The table below shows the annual net assets of BioSmart Co.Ltd from 2010 to 2024.

Year Net Assets Change
2024-12-31 ₩129.48 Billion +6.46%
2023-12-31 ₩121.63 Billion +25.75%
2022-12-31 ₩96.72 Billion -2.39%
2021-12-31 ₩99.10 Billion +2.40%
2020-12-31 ₩96.78 Billion -8.24%
2019-12-31 ₩105.47 Billion +31.03%
2018-12-31 ₩80.49 Billion +24.29%
2017-12-31 ₩64.76 Billion +9.41%
2016-12-31 ₩59.19 Billion +0.64%
2015-12-31 ₩58.82 Billion +16.57%
2014-12-31 ₩50.46 Billion +8.41%
2013-12-31 ₩46.54 Billion +21.42%
2012-12-31 ₩38.33 Billion +8.80%
2011-12-31 ₩35.23 Billion +69.89%
2010-12-31 ₩20.74 Billion --

Equity Component Analysis

This analysis shows how different components contribute to BioSmart Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6645.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩48.20 Billion 37.22%
Common Stock ₩13.08 Billion 10.10%
Other Components ₩68.20 Billion 52.67%
Total Equity ₩129.48 Billion 100.00%

BioSmart Co.Ltd Competitors by Market Cap

The table below lists competitors of BioSmart Co.Ltd ranked by their market capitalization.

Company Market Cap
Dynamic Cables Limited
NSE:DYCL
 		$46.07 Million
Midsona AB Series B
LSE:0GSE
 		$46.08 Million
Marblegate Acquisition Corp
NASDAQ:GATE
 		$46.10 Million
Malindo Feedmill Tbk
JK:MAIN
 		$46.12 Million
Exagen Inc
NASDAQ:XGN
 		$46.05 Million
Signpost India Limited
NSE:SIGNPOST
 		$46.05 Million
Hedef Girisim Sermayesi
IS:HDFGS
 		$46.05 Million
Tantalus Systems Holding Inc
OTCQX:TNTLF
 		$46.03 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BioSmart Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 111,691,289,860 to 129,484,272,150, a change of 17,792,982,290 (15.9%).
  • Net income of 127,171,570 contributed positively to equity growth.
  • Share repurchases of 7,995,831,150 reduced equity.
  • New share issuances of 8,185,331,150 increased equity.
  • Other factors increased equity by 17,476,310,720.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩127.17 Million +0.1%
Share Repurchases ₩8.00 Billion -6.18%
Share Issuances ₩8.19 Billion +6.32%
Other Changes ₩17.48 Billion +13.5%
Total Change ₩- 15.93%

Book Value vs Market Value Analysis

This analysis compares BioSmart Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.91x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.37x to 0.91x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩3396.15 ₩4640.00 x
2017-12-31 ₩3659.99 ₩4640.00 x
2018-12-31 ₩4029.04 ₩4640.00 x
2019-12-31 ₩5269.81 ₩4640.00 x
2020-12-31 ₩5041.12 ₩4640.00 x
2021-12-31 ₩5161.94 ₩4640.00 x
2022-12-31 ₩5038.31 ₩4640.00 x
2023-12-31 ₩5604.99 ₩4640.00 x
2024-12-31 ₩5123.11 ₩4640.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently BioSmart Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.10%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.03%
  • • Asset Turnover: 1.84x
  • • Equity Multiplier: 2.03x
  • Recent ROE (0.10%) is below the historical average (4.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 0.97% 1.00% 0.49x 1.99x ₩-3.13 Billion
2012 7.49% 6.74% 0.61x 1.81x ₩-955.35 Million
2013 8.47% 9.81% 0.56x 1.54x ₩-716.20 Million
2014 1.45% 1.79% 0.61x 1.33x ₩-4.37 Billion
2015 5.35% 5.81% 0.73x 1.27x ₩-2.73 Billion
2016 1.05% 0.98% 0.56x 1.89x ₩-5.30 Billion
2017 7.45% 6.00% 0.71x 1.74x ₩-1.65 Billion
2018 6.38% 4.36% 0.83x 1.76x ₩-2.91 Billion
2019 21.00% 13.93% 0.87x 1.74x ₩11.60 Billion
2020 -9.03% -5.25% 0.99x 1.74x ₩-18.41 Billion
2021 1.41% 0.74% 0.84x 2.28x ₩-8.52 Billion
2022 0.75% 0.18% 1.65x 2.45x ₩-8.95 Billion
2023 16.03% 3.93% 1.75x 2.33x ₩6.74 Billion
2024 0.10% 0.03% 1.84x 2.03x ₩-12.82 Billion

Industry Comparison

This section compares BioSmart Co.Ltd's net assets metrics with peer companies in the Electronic Equipment & Parts industry.

Industry Context

  • Industry: Electronic Equipment & Parts
  • Average net assets among peers: $84,384,889,483
  • Average return on equity (ROE) among peers: -11.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BioSmart Co.Ltd (038460) ₩178.85 Billion 0.97% 0.61x $46.07 Million
SANGBO Corp (027580) $29.45 Billion -35.18% 2.55x $19.25 Million
Inzi Display Co.Ltd (037330) $162.56 Billion 1.55% 0.59x $19.38 Million
e-LITECOM CO. Ltd (041520) $38.24 Billion 17.41% 1.56x $35.12 Million
CoAsia Corporation (045970) $100.09 Billion 0.00% 1.72x $59.77 Million
Powerlogics Co. Ltd (047310) $212.21 Billion -3.86% 1.12x $121.60 Million
Phoenix Materials Co. Ltd (050090) $27.29 Billion -7.19% 0.62x $8.87 Million
CammSys Corp (050110) $75.36 Billion 10.73% 0.88x $23.68 Million
STCube Inc (052020) $19.12 Billion -86.05% 0.38x $442.98 Million
Amotech Co. Ltd (052710) $95.14 Billion 1.97% 1.04x $55.48 Million